Toolkit/CaMKIIα promoter-based targeting
CaMKIIα promoter-based targeting
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
The supplied web research summary states that the CaMKIIα promoter is explicitly discussed in the anchor review as a cell-type-enrichment promoter for viral opsin delivery.
Usefulness & Problems
Why this is useful
CaMKIIα promoter-based targeting is used to enrich opsin expression in selected neuronal populations. In the review scaffold, it is presented as part of the targeting strategy for optogenetic experiments.; cell-type-enriched opsin expression; targeting viral optogenetic constructs
Source:
CaMKIIα promoter-based targeting is used to enrich opsin expression in selected neuronal populations. In the review scaffold, it is presented as part of the targeting strategy for optogenetic experiments.
Source:
cell-type-enriched opsin expression
Source:
targeting viral optogenetic constructs
Problem solved
It helps investigators avoid completely untargeted expression when probing stress-related circuits.; helps restrict expression to selected neuronal populations
Source:
It helps investigators avoid completely untargeted expression when probing stress-related circuits.
Source:
helps restrict expression to selected neuronal populations
Problem links
helps restrict expression to selected neuronal populations
LiteratureIt helps investigators avoid completely untargeted expression when probing stress-related circuits.
Source:
It helps investigators avoid completely untargeted expression when probing stress-related circuits.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Techniques
Selection / EnrichmentTarget processes
selectionImplementation Constraints
It requires a viral or genetic construct carrying the promoter and an opsin payload, plus the usual optical-delivery setup.; requires compatible viral delivery and construct design
The available evidence does not support claiming perfect specificity or performance across all cell classes.; described as enrichment rather than absolute specificity
Validation
Supporting Sources
Ranked Claims
Long-term in vivo optogenetic studies in this review context rely on implantable optical-fiber strategies for light delivery.
Projection-specific optogenetic manipulation is presented as a central strategy for dissecting stress-related circuitry.
The review discusses promoter-based targeting such as CaMKIIα to enrich opsin delivery to selected neuronal populations.
The review discusses both excitatory and inhibitory optogenetic actuators for causal manipulation of stress-related neural circuits.
Approval Evidence
The supplied web research summary states that the CaMKIIα promoter is explicitly discussed in the anchor review as a cell-type-enrichment promoter for viral opsin delivery.
Source:
The review discusses promoter-based targeting such as CaMKIIα to enrich opsin delivery to selected neuronal populations.
Source:
Comparisons
Source-stated alternatives
The supplied summary also mentions marker-based strategies involving Vgat and Vglut2 as nearby targeting approaches.
Source:
The supplied summary also mentions marker-based strategies involving Vgat and Vglut2 as nearby targeting approaches.
Source-backed strengths
provides a targeting layer for viral opsin delivery
Source:
provides a targeting layer for viral opsin delivery
Compared with inkube
CaMKIIα promoter-based targeting and inkube address a similar problem space because they share selection.
Shared frame: same top-level item type; shared target processes: selection
Compared with synthetic promoters
CaMKIIα promoter-based targeting and synthetic promoters address a similar problem space because they share selection.
Shared frame: same top-level item type; shared target processes: selection
Relative tradeoffs: appears more independently replicated; looks easier to implement in practice.
Compared with thyrotropin suppression therapy using levothyroxine
CaMKIIα promoter-based targeting and thyrotropin suppression therapy using levothyroxine address a similar problem space because they share selection.
Shared frame: same top-level item type; shared target processes: selection
Ranked Citations
- 1.